Genomics of Acute Myeloid Leukemia at Diagnosis and Remission
Kai Yu(Virginia Cancer Institute), Lori Muffly(Stanford University), Melhem Solh(Johns Hopkins Hospital), Sandeep Gurbuxani(University of Chicago), James Han(Illumina (United States)), Hetty E. Carraway(Cleveland Clinic), Vidya Kudlingar(Illumina (United States)), Michael W. Drazer(Susan Thompson Buffett Foundation), Christina K. Ferrone(National Cancer Institute), Rahul S. Vedula(Harvard University), Farah Sahoo(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Hanjoong Jo(The Wallace H. Coulter Department of Biomedical Engineering), Yi‐Bin Chen(Massachusetts General Hospital), Reena Jayani(Vanderbilt University Medical Center), Sam Ng(University of California, Santa Cruz), Severine Catreux(Illumina (United States)), Michael R. Grunwald(Levine Cancer Institute), Jesse M. Tettero(Amsterdam Neuroscience), Sophia Balderman(Cleveland Clinic), Gege Gui(Johns Hopkins University), Laura W. Dillon(Institute of Cancer Research), Jamie Diemer(National Institutes of Health), Elizabeth A. Griffiths(Roswell Park Comprehensive Cancer Center), Alexandra Gomez-Arteaga(Cornell University), Yutong Qiu(Illumina (United States)), Lawrence J. Druhan(Lung Institute), Brian C. Shaffer(Memorial Sloan Kettering Cancer Center), Cecilia C.S. Yeung(University of Washington), Amandeep Salhotra(City of Hope), Nelli Bejanyan(Moffitt Cancer Center), Khai Luong(Pacific Biosciences (United States)), Elizabeth F. Krakow(Fred Hutch Cancer Center), Melissa Y. Tjota(University of Chicago), Antonio Martin Jimenez-Jimenez(Sylvester Comprehensive Cancer Center), Aaron C. Logan(University of California, San Francisco), James S. Blachly(The Ohio State University Wexner Medical Center), Amir T. Fathi(Harvard University), Wilfred W. Li(Illumina (United States)), Yunjiao Zhu(Illumina (United States)), Vanessa E. Kennedy(Palo Alto University), Jason Hu(Illumina (United States)), Reem Bahr(National Institutes of Health), Sean Truong(Illumina (United States)), Rasha W Al-Ali(Institute of Cancer Research), Dylan Barfield(Illumina (United States)), Pratheesh Sathyan(Illumina (United States)), Allison J Getker(Carilion Clinic)
Cited by 0
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
|New England Journal of Medicine|2016|601